These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 301055

  • 1. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer.
    Lopez DM, Voigt W.
    Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055
    [Abstract] [Full Text] [Related]

  • 2. Characterization of prostate carcinoma lines in the Copenhagen rat.
    Voigt W, Lopez DM.
    Natl Cancer Inst Monogr; 1978 Dec; (49):269-73. PubMed ID: 748780
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Dunning R3327 prostate adenocarcinoma in the Fischer-Copenhagen F1 rat: a useful model for immunological studies.
    Claflin AJ, McKinney EC, Fletcher MA.
    Oncology; 1977 Dec; 34(3):105-9. PubMed ID: 917439
    [Abstract] [Full Text] [Related]

  • 5. A novel immunological model for the study of prostate cancer.
    Sharma N, Luo J, Kirschmann DA, O'Malley Y, Robbins ME, Akporiaye ET, Lubaroff DM, Heidger PM, Hendrix MJ.
    Cancer Res; 1999 May 15; 59(10):2271-6. PubMed ID: 10344727
    [Abstract] [Full Text] [Related]

  • 6. Rat prostate carcinoma 11095-A: profile of organ- and tumor-specific antigens.
    Lande IJ, Feldbush TL, Lubaroff DM, Bonney WW.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):283-7. PubMed ID: 86165
    [Abstract] [Full Text] [Related]

  • 7. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Neeley YC, Arredouani MS, Hollenbeck B, Eng MH, Rubin MA, Sanda MG.
    Prostate; 2008 May 15; 68(7):715-27. PubMed ID: 18302222
    [Abstract] [Full Text] [Related]

  • 8. Studies on a weakly immunogenic squamous cell carcinoma of the rat prostate.
    Lande IJ, Feldbush TL, Lubaroff DM.
    Invest Urol; 1980 Mar 15; 17(5):419-24. PubMed ID: 7358506
    [Abstract] [Full Text] [Related]

  • 9. Immunological studies of prostate adenocarcinoma in an animal model.
    Claflin AJ, McKinney EC, Fletcher MA.
    Prog Clin Biol Res; 1980 Mar 15; 37():365-77. PubMed ID: 7384093
    [No Abstract] [Full Text] [Related]

  • 10. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA, Lucas ZJ.
    J Immunol; 1977 Aug 15; 119(2):726-36. PubMed ID: 328781
    [No Abstract] [Full Text] [Related]

  • 11. Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from Dunning prostatic adenocarcinoma challenge.
    Friedman EJ, Orth CR, Brewton KA, Ponniah S, Alexander RB.
    J Urol; 1997 Oct 15; 158(4):1585-8. PubMed ID: 9302178
    [Abstract] [Full Text] [Related]

  • 12. Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma.
    Coffey DS, Smolev J, Heston WD, Scott WW.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):289-91. PubMed ID: 748782
    [Abstract] [Full Text] [Related]

  • 13. Immunobiology of carcinoma of the prostate.
    Catalona WJ.
    Invest Urol; 1980 Mar 15; 17(5):373-7. PubMed ID: 6987190
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
    Johnson LE, Frye TP, Arnot AR, Marquette C, Couture LA, Gendron-Fitzpatrick A, McNeel DG.
    Vaccine; 2006 Jan 16; 24(3):293-303. PubMed ID: 16115700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.